Cytomegalovirus (CMV) is the most common opportunistic viral infection to occur following
solid-organ transplantation. This review will discuss the current strategies of management of …

Cytomegalovirus (CMV) is the most common viral pathogen in organ transplant recipients.
The patients at highest risk of developing CMV disease are seronegative recipients of …

AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

Whether preemptive therapy or universal prophylaxis with ganciclovir is the optimal
approach against cytomegalovirus (CMV) remains unresolved. Controversy abounds with …

Primary cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in
recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral …

Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient …

Background. Recurrent infection frequently follows the response to the initial treatment of
cytomegalovirus (CMV) infection in solid-organ transplant (SOT) recipients. The objective of …

Cytomegalovirus (CMV) has been recognized as one of the most important opportunistic
pathogens in transplant recipients. Direct clinical syndromes due to CMV are associated …

There is notable heterogeneity in the implementation of cytomegalovirus (CMV) prevention
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …

Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …